BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6386149)

  • 1. Analysis of antigenic expression by primary and autologous metastatic human sarcomas using murine monoclonal antibodies.
    Roth JA; Restrepo C; Scuderi P; Baldwin RW; Reichert CM; Hosoi S
    Cancer Res; 1984 Nov; 44(11):5320-5. PubMed ID: 6386149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tumor-associated antigens detected by serological techniques: analysis of autologous humoral immune responses to primary and metastatic human sarcomas by an enzyme-linked immunoabsorbent solid-phase assay (ELISA).
    Roth JA; Wesley RA
    Cancer Res; 1982 Oct; 42(10):3978-86. PubMed ID: 6955005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
    Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
    Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas.
    Yoshida SO; Imam A
    Cancer Res; 1989 Apr; 49(7):1802-9. PubMed ID: 2466563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
    Roth JA; Scuderi P; Westin E; Gallo RC
    Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR (Ia-like) reactivity in tumors of bone and soft tissue: an immunohistochemical comparison of monoclonal antibodies LN3 and LK8D3 in routinely processed specimens.
    Swanson PE; Wick MR
    Mod Pathol; 1990 Mar; 3(2):113-9. PubMed ID: 1691491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
    Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
    Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
    Brown JM
    Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
    Hand PH; Nuti M; Colcher D; Schlom J
    Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.
    Fargion S; Carney D; Mulshine J; Rosen S; Bunn P; Jewett P; Cuttitta F; Gazdar A; Minna J
    Cancer Res; 1986 May; 46(5):2633-8. PubMed ID: 3008997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.
    Natali PG; Cavaliere R; Bigotti A; Nicotra MR; Russo C; Ng AK; Giacomini P; Ferrone S
    J Immunol; 1983 Mar; 130(3):1462-6. PubMed ID: 6600484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody identification and characterization of two human sarcoma-associated antigens.
    Stastny JJ; Brown JM; Beattie CW; Das Gupta TK
    Cancer Res; 1991 Jul; 51(14):3768-73. PubMed ID: 2065331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors.
    Byers VS; Johnston JO
    Cancer Res; 1977 Sep; 37(9):3173-83. PubMed ID: 69491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.
    Croghan GA; Papsidero LD; Valenzuela LA; Nemoto T; Penetrante R; Chu TM
    Cancer Res; 1983 Oct; 43(10):4980-8. PubMed ID: 6349797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human osteosarcoma-associated antigen(s) by monoclonal antibodies.
    Hosoi S; Nakamura T; Higashi S; Yamamuro T; Toyama S; Shinomiya K; Mikawa H
    Cancer Res; 1982 Feb; 42(2):654-9. PubMed ID: 6173116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
    Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
    Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
    Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
    Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.